Compare ASR & ALGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ASR | ALGN |
|---|---|---|
| Founded | 1996 | 1997 |
| Country | Mexico | United States |
| Employees | N/A | N/A |
| Industry | Aerospace | Industrial Specialties |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.5B | 12.0B |
| IPO Year | 2000 | N/A |
| Metric | ASR | ALGN |
|---|---|---|
| Price | $373.51 | $186.77 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 11 |
| Target Price | ★ $337.50 | $189.40 |
| AVG Volume (30 Days) | 66.8K | ★ 1.3M |
| Earning Date | 02-24-2026 | 02-04-2026 |
| Dividend Yield | ★ 10.13% | N/A |
| EPS Growth | N/A | ★ 0.53 |
| EPS | 2.03 | ★ 5.65 |
| Revenue | $1,923,920,463.00 | ★ $4,034,964,000.00 |
| Revenue This Year | $13.32 | $5.33 |
| Revenue Next Year | $10.82 | $4.61 |
| P/E Ratio | ★ $18.22 | $33.06 |
| Revenue Growth | ★ 20.90 | 0.90 |
| 52 Week Low | $249.21 | $122.00 |
| 52 Week High | $379.07 | $208.65 |
| Indicator | ASR | ALGN |
|---|---|---|
| Relative Strength Index (RSI) | 69.52 | 61.49 |
| Support Level | $362.69 | $154.83 |
| Resistance Level | $379.07 | $199.06 |
| Average True Range (ATR) | 9.64 | 7.59 |
| MACD | 1.44 | 1.97 |
| Stochastic Oscillator | 84.70 | 72.21 |
Grupo Aeroportuario del Sureste SAB de CV and its subsidiaries hold concessions to operate, maintain, and develop airports in the southeast region of Mexico. As an operator of airports, it charges airlines, passengers, and other users fees for using the airports' facilities. The group also derives rental and other income from commercial activities conducted at its airports, such as the leasing of space to restaurants and retailers. The group's operating segments are Cancun, which generates maximum revenue, Aerostar, Airplan, Merida, Villahermosa, Holding and Services, and Others.
Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.